Background Drug-eluting bioabsorbable stents (DEBSs) represent a new device-based therapy for coronary artery disease. It has been reported that the stented segment becomes reendothelialized after 1 month and the segments…
Background The presence of end-stage renal disease (ESRD) after percutaneous coronary interventions (PCIs) is associated with poor outcomes, but the specific contribution of diabetes mellitus (DM) is not established. Methods…
Background Endovascular treatment has been used increasingly for the treatment of carotid artery stenosis. Studies of carotid artery stenting have shown conflicting results. Methods To address this disparity, we reviewed…
Background Popliteal aneurysms (PAs) are the most frequent peripheral artery aneurysms, and those of more than 2 cm in diameter are considered candidates for elective surgery. Although the standard treatment…
Background Optimal timing and mode of treatment for patients with coarctation of the aorta (COA) remain controversial, particularly in children. Surgery, balloon dilatation and stent implantation have all proven effective…
Background The effect of debulking on nitinol self-expanding (n-SES) stent deployment in the superficial femoral artery (SFA) has never been systematically assessed. Objective The objective was to evaluate hemodynamic differences…
Background Thrombus is highly prevalent in patients with recent symptoms (<6 months) of claudication or limb ischemia and occluded culprit lower extremity vessels. Treatment of these thrombotic occlusions is challenging….
Background Target lesion revascularization (TLR) with primary percutaneous transluminal angioplasty (PTA) vs. cryoplasty (CRYO) in the treatment of de novo infrainguinal disease has not been well defined in randomized trials….
Background Patients undergoing administration of thrombolytic therapy for deep venous thrombosis (DVT) have been reported to have major bleeding rates of 5%–10%. These results stem from older data with dosing…
Background Patients (pts) undergoing pacemaker and/or cardioverter–defibrillator (PM/ICD) implantation/upgrade might have difficult access due to sub/total central vein occlusions, usually related to prior venous manipulation. This study aimed to describe…
